Ontology highlight
ABSTRACT: Purpose
Carbonyl reductases (CBRs) catalyze reduction of anthracyclines to cardiotoxic alcohol metabolites. Polymorphisms in CBR1 and CBR3 influence synthesis of these metabolites. We examined whether single nucleotide polymorphisms in CBR1 (CBR1 1096G>A) and/or CBR3 (CBR3 V244M) modified the dose-dependent risk of anthracycline-related cardiomyopathy in childhood cancer survivors.Patients and methods
One hundred seventy survivors with cardiomyopathy (patient cases) were compared with 317 survivors with no cardiomyopathy (controls; matched on cancer diagnosis, year of diagnosis, length of follow-up, and race/ethnicity) using conditional logistic regression techniques.Results
A dose-dependent association was observed between cumulative anthracycline exposure and card
SUBMITTER: Blanco JG
PROVIDER: S-EPMC3383117 | biostudies-literature | 2012 May
REPOSITORIES: biostudies-literature